Research Celebration Event

Celebrating
research...
Research, Development and Innovation

Agenda

Friday 8 April 2022

Canham Turner, University of Hull, Cottingham Road, HU6 7RX

TimeSessionSpeaker
08:30-09:00Registration and coffee 
09:00-09:05Welcome and Opening Remarks – Dean of the Faculty of Health Sciences, University of HullProf Paul Hagan
09:05-09:10Opening Remarks – Chief Executive, Hull University Teaching Hospitals NHS TrustMr Christopher Long
09:15-09:45Keynote Speech – Vice President of Research and Innovation, Smith and NephewMr Stewart McKinlay
Chair: Prof Sunil Bhandari  
09:45-10:05Generating Evidence and Improving Patient Care through CollaborationDr Michael Crooks
10:05-10:25Infection Research Group: Beyond COVIDDr Gavin Barlow, Dr Nicholas Easom and Dr Patrick Lillie
10:25-10:45A Hull Biomedical Institute for Multimorbidity To Drive Translational Research for Patient BenefitProf Tim Palmer
10:45-11:15Get connected with coffee 
Chair: Prof Alyn Morice  
11:15-11:35Rehabilitation research: The new frontier; Therapies Research – Stronger togetherDr Abayomi Salawu and Dr Angela Green
11:35-11:55Translational Research at the Hull Molecular Imaging Centres (HuMIC)Prof Steve Archibald and Dr Azeem Saleem
11.55-12:15Advanced wound care research at Hull; discovery science, industry partnering and patient benefitProf Matthew Hardman
12:15-12:35Hull Health Trials Unit (facilities and opportunities)Dr Judith Cohen and Mr John Turgoose
12:35-14:30Networking lunch and poster exhibits 
Chair: Prof Thozhukat Sathyapalan  
14:30-14:50Integrating research into frontline clinical practiceProf Shaji Sebastian and Dr Lynsey Corless
14:50-15:10Orthopaedic Research; Past, Present and Future?Prof Hemant Sharma
15:10-15:30My research in paediatric urology and other animalsMiss Anna Radford
15:30-15:50National palliative care research during COVID; the CovPall study.Prof Fliss Murtagh
15:50-16:05Future Plans – HYMS PerspectiveProf Una Macleod
16:05-16:20Future Plans – HUTH Perspective Feedback and closing remarksProf Makani Purva

Speakers

Prof Paul Hagan

Prof Paul Hagan

Dean of the Faculty of Health Sciences, University of Hull

Professor Hagan began his career in academia as a PhD student at the University of Glasgow. On completion of his PhD he joined the Medical Research Council Unit at Fajara, The Gambia, in 1981, to begin research on the immunology and epidemiology of human schistosomiasis (a disease caused by a parasitic worm disease which affects hundreds of millions of people in tropical countries around the globe). He continued this work when he moved to join the National Institute for Medical Research in London, developing partnerships with researchers in Egypt, Zimbabwe and many other countries in sub-Sharan Africa.

Professor Hagan is an Advisor to the World Health Organisation on Parasitic Diseases and currently chairs the WHO Guidelines Development Group (GDG) for the control and elimination of schistosomiasis. He holds Honorary Membership of the British Society for Parasitology and is a Fellow of the Royal Society of Edinburgh, Scotland’s National Academy.

He joins the University of Hull after five years at Robert Gordon University, where he was Vice-Principal (Research) and Deputy Principal. Prior to that, he was Director of Research and Innovation at the Scottish Further and Higher Education Council, where he made many contributions, including establishing Scotland’s Innovation Centre Programme.

Professor Hagan’s career also spans twenty years in various roles at the University of Glasgow, as Head of the Division of Infection and Immunity and Dean of the Faculty of Biomedical and Life Sciences. Between 1995-1998, he was seconded from Glasgow to the European Commission in Brussels where he had responsibility for the Parasitology portfolio within the International Cooperation with Developing Countries Programme (INCO-DC).

Mr Christopher Long

Mr Christopher Long

Chief Executive, Hull University Teaching Hospitals

Chris served for 12 years in the Army as an infantry officer before coming into NHS management in 1991. He worked in a variety of roles before being appointed Chief Executive of one of the first primary care trusts (PCTs) in 2002. He moved to Hull PCT as Chief Executive in 2004, where he stayed until PCTs were abolished in 2013. Following a brief spell in NHS England he was appointed as Chief Executive of our Trust in October 2014.

Mr Stewart McKinlay

Mr Stewart McKinlay

Vice President, Global R&D for Smith + Nephew Advanced Wound Management

Stewart is the Vice President, Global R&D for Smith + Nephew Advanced Wound Management. S+N Wound Management has World class R&D teams and facilities in the US and here in Hull which is the Global R&D Centre for Advanced Wound Management. Nearly 200 scientists and engineers working across early research, technology partnering, new product development, project management and clinical trials.

Stewart has been 18 years at Smith + Nephew Wound Management with 14 years of leading R&D.

Stewart has personally overseen over 50 new product launches in the Wound Management sector across dressings, active antimicrobials, Negative Pressure Wound Therapy, electro-mechanical devices, Biologics, sensors, Data and Mobile Apps. He has over 30 years of Medical Device, Pharmaceutical and flexible film manufacturing and R&D experience.

Smith + Nephew is the UK’s largest Medical Device Manufacturer with 18,000 employees worldwide and started in Hull 160 years ago.

Dr Michael Crooks

Dr Michael Crooks

Senior Clinical Lecturer and Honorary Consultant in Respiratory Medicine, Hull York Medical School

Michael was appointed as a Senior Clinical Lecturer and Honorary Consultant in Respiratory Medicine in 2016 and works in the Respiratory Research Group within the Institute of Clinical and Applied Health Research, Hull York Medical School.

He undertook his undergraduate training in Dundee before moving to Edinburgh where he completed his Foundation Training. He moved to Hull in 2009 as an NIHR Academic Clinical Fellow before completing his MD. He was subsequently awarded an NIHR Clinical Lecturer position at Hull York Medical School where he developed his interest in airways diseases including asthma and COPD.

Michael is a member of the Hull University Teaching Hospitals Airways Team and leads the local integrated COPD service. He leads a range of clinical trials and other research projects relating to the diagnosis and management of airways disease and their exacerbations.

Michael is committed to the delivery of medical education and improving patient care. He is the programme lead for the SENTINEL Project which aims to improve asthma outcomes in the region, he chairs the Hull and East Yorkshire Respiratory Education group and is the Clinical Lead for the Humber Coast and Vale Respiratory Network.

Dr Gavin Barlow

Dr Gavin Barlow

Clinical Lecturer in Infection and Academic Phase III (Final Year) Lead, Hull York Medical School and Honorary Consultant in Infection, Hull University Teaching Hospitals

Gavin is Senior Clinical Lecturer in Infection at Hull York Medical School and Hon. Consultant in Infection at Hull University Teaching Hospitals. Clinical experience is broad, but his main interests are orthopaedic infection, outpatient IV antibiotic therapy, complex bacterial infection, and antibiotic stewardship (previously trust lead 2005-19). Research interests include but are not limited to antimicrobials, antimicrobial stewardship and resistance, respiratory infections, the epidemiology of community and hospital-acquired infections, bacteraemia, and prognostic prediction in infection.

Gavin is co-chief-investigator of the NIHR funded BioDriveAFS trial - due to start March 2022 - that aims to compare a biomarker/diagnostics driven approach to antifungal management in patients with blood cancers and receiving chemotherapy versus the current standard of care.

Dr Nicholas Easom

Dr Nicholas Easom

Consultant in Infection, Hull University Teaching Hospitals and Honorary Senior Lecturer, Hull York Medical School

Founder member of the Infection Research Group at Hull University Teaching Hospitals. Principal Investigator for RECOVERY and HEAL-COVID phase 3 clinical trials in COVID-19, for PHOSP-COVID observational study in Long-COVID and SIREN observational study of COVID in healthcare workers, and for a pharma-led phase 2 trial examining novel therapeutics in hepatitis B infection. Involved in the development of capacity for GM vaccine research in Hull. Supervises academic trainees and clinical fellows with projects on COVID-19 and hepatitis B. Leads on medical student teaching within Infectious Diseases at HUTH.

Dr Patrick Lillie

Dr Patrick Lillie

Consultant in Infection, Hull University Teaching Hospitals and Honorary Senior Lecturer, Hull York Medical School

Dr Patrick Lillie graduated from Leicester University medical school in 2002, and trained in infectious diseases and general medicine in Birmingham, Hull, Leeds and Sheffield. He undertook research in Oxford and Sheffield, with a PhD from the University of Sheffield. He returned to Hull in 2017 as a consultant in infection and honorary senior lecturer. Research interests include clinical vaccine trials, injecting drug use related bacterial infections, severity assessment of infection and longer-term effects of acute infection. He has been PI on four COVID vaccine trials locally.

Prof Tim Palmer

Prof Tim Palmer

Professor of Cardiovascular Biology and Head of the Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School

Tim obtained an Honours degree in Biochemistry at the University of Manchester and a PhD in Molecular Pharmacology at the University of Glasgow. He carried out postdoctoral training as an American Heart Association Research Fellow in the Cardiology Division at Duke University Medical Centre, North Carolina, USA.

He returned to the UK in 1997 as a Lecturer in Biochemistry at the University of Glasgow and developed an externally funded research programme focusing on cardiovascular cell signalling and disease.

From 2015 he was Professor of Pharmacology and Head of Pharmacology and Experimental Therapeutics at the School of Pharmacy and Medical Sciences at the University of Bradford before taking up his position in Hull in 2018.

Dr Abayomi Salawu

Dr Abayomi Salawu

Rehabilitation Medicine Consultant, Hull University Teaching Hospitals and Honorary Senior Clinical Lecturer, Hull York Medical School

Dr Abayomi Salawu is rehabilitation medicine consultant with the Hull University teaching Hospital NHS Trust and an honorary senior clinical lecturer with Hull/York Medical School (HYMS). He is also an honorary senior lecturer with the University of Hull Sports Science department. His clinical areas of interest include Musculoskeletal Rehabilitation, Traumatic Brain Injury Rehabilitation, Amputee Rehabilitation and Exercise Medicine. He has an on-going research project on the use of gripAble rehabilitation tool in patients with upper limb spasticity receiving botulinum toxin. He actively promotes and encourages increased participation in sports and physical activities by people with physical disabilities. He has a special interest in the use of technology to improve rehabilitation outcomes. Since the onset of the COVID-19 pandemic, he has been actively involved in the rehabilitation of patients with COVID-19 and is the clinical lead of the Humber long COVID triage and assessment service.

Dr Angela Green

Dr Angela Green

Lead Clinical Research Therapist, Hull University Teaching Hospitals

Angela graduated as a physiotherapist in 1987 and specialised in neurological rehabilitation (children and adults) in both acute and community NHS Trusts. She now supports people with cancer related fatigue and is involved in recruitment for a number of national research studies. Angela’s PhD (awarded in 2008), focussed on patient involvement in physiotherapeutic consultations. She has been a fellow of the National Institute for Health and Care Excellence. She has also worked in the Yorkshire and Humber region to increase Allied Health Professional engagement in research, in conjunction with the NIHR Yorkshire clinical research network, and as a hub lead for the Council for Allied Health Professional Research (CAHPR) network. Her current research interests lie in person-centred practice and rehabilitation, particularly in relation to long COVID. Angela is passionate about increasing the visibility of Allied Health Professionals (AHPs) at system level and increasing AHP engagement in research.

Prof Steve Archibald

Prof Steve Archibald

Professor in Molecular Imaging, University of Hull

Prof Archibald was awarded a first class BSc degree in Chemistry, Life Systems and Pharmaceuticals by the University of York in 1992 and a PhD in Chemistry by the University of Edinburgh in 1995.

He carried out postdoctoral research at the Universities of Paris-Sud (France), Kansas (USA) and York (UK), before being appointed as a lecturer at the University of Hull in 2000.

Prof Archibald was promoted to Senior Lecturer in 2008, Reader in 2011, Director of the Positron Emission Tomography Research Centre in 2013 and Professor in 2014.

Research areas in the Archibald group are PET probe development, chemokine receptor imaging and lab-on-a-chip / microfluidic devices for radiosynthesis and quality control.

Dr Azeem Saleem

Dr Azeem Saleem

Reader at the University of Hull and Honorary Consultant in Clinical Oncology, Hull University Teaching Hospitals

Dr Azeem Saleem is a clinical oncologist with a research background in molecular imaging and has wide experience working in industry and academia. He joined the Hull York Medical School, University of Hull in December 2019 as a Reader and as an honorary consultant in clinical oncology at the Hull University Teaching Hospitals. Saleem did his research fellowship at the Medical Research Council (MRC) Cyclotron Unit, Hammersmith Hospital, London between 1997 and 2000, evaluating the utility of positron emission tomography (PET) in anti-cancer drug development to obtain his PhD. He then went on to complete his specialist training in Clinical Oncology at Merseyside.

He was appointed as a Honorary Consultant and Senior Clinical Research Fellow at the University of Manchester and the Christie Hospital in 2005. In 2009, he joined the GlaxoSmithKline Clinical Imaging Centre at the Hammersmith Hospital to lead the oncology imaging programme and as an honorary senior clinical lecturer at Imperial College. From 2011 to 2017, he headed oncology and respiratory medicine applications at Imanova Centre for Imaging Sciences, a joint venture between Imperial College, University College London, Kings College London and MRC and from 2018 until 2019, he was the UK Head of Oncology at Invicro, a Konica Minolta Company. As the Clinical Research Lead at the Hull Molecular Imaging Centres (HuMIC), he is leading in the development of the clinical research programme at HuMIC.

Prof Mat Hardman

Prof Mat Hardman

Director of Research and Chair in Wound Healing, Hull York Medical School, University of Hull

Professor Hardman has more than 20 years' experience in the field of skin biology, with a specific focus on translational wound healing studies. He leads the Advanced Wound group at Hull, which spans basic biology and translational models through to clinical studies. The group work closely with multiple industry partners and colleagues in the Hull University Teaching Hospitals, and HYMS Clinical Sciences group, ensuring a clear route to patient benefit.

Professor Hardman is Academic Lead for the University of Hull's strategic research collaborations with both Smith + Nephew and Reckitt. He leads the "clinical application of microbiome profiling" and "immune cell markers in chronic disease" PhD clusters. Research and Knowledge Exchange activity in the Wound group is supported by NIHR, Innovate UK, Help for Health, The National Biofilms Innovation Centre, Diabetes UK, The British Skin Foundation and a range of industry partners.

Before moving to Hull in 2016, Mat was Director of the EPSRC and MRC Centre for Doctoral Training in Regeneration Medicine at the University of Manchester.

Dr Judith Cohen

Dr Judith Cohen

Director of the Hull Health Trials Unit (HHTU), University of Hull

Judith has a BSc in Medical Biochemistry from the University of Leicester, and a PhD in the biochemistry of wound healing from the University of Sheffield. She completed early post-doctoral work at the University of Manchester, before moving into clinical trials at the Wolfson Molecular Imaging Centre. She joined Sheffield Clinical Trials Research Unit (CTRU) in 2007, and developed expertise in clinical trials methodology, including the design and implementation of large scale randomised controlled trials (RCTs).

She was appointed as Director of the Hull Health Trials Unit (HHTU) in November 2017, and as a Clinical Trials methodologist within the University of Hull Institute of Clinical and Applied Health Research (ICAHR) Methods Hub. She led on establishing the HHTU and attaining UKCRC CTU provisional registration (registration number 68). HHTU is an academic-led clinical trials unit which houses a multidisciplinary team with expertise in clinical trial design, conduct and analysis. HHTU works in collaboration with NHS clinicians, academics and industry partners to centrally coordinate multi-centre clinical trials and other well-designed studies including CTIMPs. The HHTU study portfolio demonstrates success in obtaining funding from a range of funders including NIHR, MRC and Industry partners and expertise across a range of clinical areas, interventions and study designs.

Mr John Turgoose

Mr John Turgoose

Information Systems Manager, Hull Health Trials Unit (HHTU), University of Hull

John holds an MSc in Information Systems and has 18 years' experience working in data roles within academic clinical trials units.

John joined the Hull Health Trials Unit in 2018 as part of the senior management team. He established the data management team and systems required to deliver large multi-centre clinical trials including regulated CTIMPs. Prior to this John was the Application Development Manager at the Clinical Trials Research Unit at the University of Leeds.

John lead the establishment of the University of Hull’' Data Safe Haven, which became operational in summer 2020. This realised a long-held ambition of the University to deliver a trusted research environment, with the security and accreditations required to house and analyse sensitive datasets. Delivered by the HHTU, this service is available to researchers across the university.

Prof Shaji Sebastian

Prof Shaji Sebastian

Consultant Gastroenterologist and Inflammatory Bowel Disease (IBD) service lead clinician, Hull University Teaching Hospitals

Professor Sebastian (Seb) is the lead clinician at the IBD unit in Hull University teaching Hospitals, Hull. He leads an integrated IBD Unit (IBD HULL) of clinical and research staff, which prides in personalised care models for IBD patients. IBD Hull has gained recognition as one of the most research active IBD units in the UK and collaborates in several multicentre national and international IBD studies. He is chief investigator in 7 ongoing multicentre studies including 3 pan European studies. The current research areas include pharmacogenomics, Transcriptomics, novel risk prediction in acute severe colitis, multimodal approach to perianal Crohn's disease, Inception cohort studies, pharmaco-epidemiology. He has over 300 peer-reviewed publications focussing on IBD (H- index 44). He was awarded the NIHR Royal College of Physicians research award for outstanding contribution to research in 2016 and National BAME researcher of the year award in 2019. Seb chairs the prestigious CLINICOM committee of European Colitis and Crohn's Organisation (ECCO) and member of CONFER Task Force committees of ECCO. He has been co-author for a number of European Colitis and Crohn`s Organisation (ECCO) guidelines and workshops in various aspects of IBD. He is the research committee chair of the South Asian IBD Alliance (SIAA), a global patient and healthcare provider organisation focusing on IBD among south Asian diaspora. Nationally, he is the chair of the BSG research committee and exec committee member, current member of IBD CRG, International committee, lead of the IBD subgroup of BSG AI task force and past chair of the adolescent Section of British Society of Gastroenterology. In addition, he leads the Y&H NIHR LCRN gastroenterology speciality.

Dr Lynsey Corless

Dr Lynsey Corless

Consultant Gastroenterologist, Hull University Teaching Hospitals

Lynsey Corless is a Consultant Hepatologist at Hull University Teaching Hospitals. She qualified in medicine at the University of Aberdeen in 2001. She trained in Aberdeen and Yorkshire, and gained her PhD in Molecular and Cellular Biology at the University of Leeds in 2010.

Since moving to Hull in 2014 to take up her consultant post, she has represented the Yorkshire LCRN as Regional Specialty Lead for Hepatology, and has now been appointed as the National Specialty Lead for the Hepatology CRN.

She leads the Hull Hepatology Research Department where as well as contributing to national and international trials, there is a local research program focussing on NAFLD and Alcohol. Main areas of interest are community management of liver disease and the impact of inequality on healthcare utilisation and outcomes.

Dr. Corless also has an active interest in training the next generation of clinical researchers and is co-founder and Director of the NIHR Gastroenterology and Hepatology Clinical Research Programme.

Prof Hemant Sharma

Prof Hemant Sharma

Honorary Professor in Trauma and Orthopaedics, Hull York Medical School and Consultant Orthopaedic Surgeon, Hull University Teaching Hospitals

Prof Hemant Sharma is an Honorary Professor in Trauma and Orthopaedics at Hull York Medical school, University of Hull. He is also a consultant orthopaedic surgeon at Hull University Teaching Hospitals, where he leads a tertiary unit in limb reconstruction and bone infections.

Hemant had his initial training in India and further training in Newcastle and the Yorkshire region. He did his limb reconstruction fellowship at Belfast.

Hemant is a keen researcher and working on developing PROMS for limb reconstruction. Apart from other studies, he is CI of multiple trials including multi-centre (and International) ACTIVE trial on Pilon fractures. Hemant is the recipient of total research grants worth over £4.3 million.

Hemant has published widely in peer review journals and multiple book chapters. He is also an invited speaker travelling extensively within the UK and internationally, delivering lectures and teaching at various courses, national meetings, and world congresses. Hemant runs the internationally renowned deformity course in Hull.

Hemant is the President for British Limb reconstruction society (BLRS), Chair of Limb reconstruction committee of SICOT (International Society of Orthopaedic surgery and Traumatology), Europe director for World association against infections in orthopaedics and trauma (WAIOT) and Member BOA research committee.

He strongly believes in "free / affordable education for all". Hemant is working with multiple international agencies, developing orthopaedic training program, running courses and teaching in LMIC countries.

Miss Anna Radford

Miss Anna Radford

Honorary Senior Clinical Lecturer, Hull York Medical School and Consultant Paediatric Surgeon and Urologist, Hull University Teaching Hospitals

Anna Radford is a Consultant Paediatric Surgeon with a specialist interest in Paediatric Urology working both at Hull University NHS Trust and Leeds Children's Hospital. She is a Senior Clinical Lecturer at Hull York Medical School (HYMS). Her developing clinical interests are spina bifida, bladder dysfunction and robotics.

Anna obtained her MBBS from Imperial College in 2005, and intercalated in 2003, obtaining a lab-based BSc evaluating the role of Interleukin-8 in colorectal cancer. After spending 3 months in Hong Kong in a Paediatric Urology department Anna completed her Foundation Training in the Northwest Thames region and moved to the Yorkshire region to complete her surgical training.

Anna took an Out of Programme in Research period from 2012 with HYMS and obtained her PhD in the summer 2015 for her thesis entitled "Regenerative Medicine Applications in Paediatric Urology: Barriers and Solutions". Her ongoing research activities continue in the areas of tissue engineering in the urinary tract and bladder, particularly pertaining to the treatment of children with spina bifida and neuropathic bladders.

Associated with these abnormalities Anna has also developed research projects addressing the causes of recurrent urinary tract infections in children and how medical innovations in diagnostics could help improve the care provided. Related to this work she has recently formed several research collaborations with orthopaedic surgeons, neurosurgeons, and veterinary surgeons.

By working with members of the veterinary research community Anna has been welcomed globally into the up-and-coming fields of One Health and One Medicine. These two concepts aim to improve the efficacy, efficiency and ethical practice of research involving humans, animals, and the environment by recognising the interplay and commonality between all three.

She is now an honorary member of the "Young" Academic Working Group in Paediatric Urology in the European Association of Urology and reviews for several journals in the field of Paediatric Urology. Anna also mentors' young people from disadvantaged backgrounds who aspire to careers in medicine, surgery, research and one health.

Dr Fliss E M Murtagh, FRCP PhD MRCGP MBBS

Dr Fliss E M Murtagh, FRCP PhD MRCGP MBBS

NIHR Senior Investigator

Fliss works as Honorary Consultant in Palliative Medicine at Hull University Teaching Hospitals, Professor of Palliative Care at Hull York Medical School, and Visiting Professor of Palliative Care at the Cicely Saunders Institute, King's College London, UK.

She is experienced in providing palliative care to a wide range of people with far advanced disease and their families, and has published extensively (Scopus-indexed publications 175, Scopus H-Index 39), on palliative and end-of-life care needs, especially for older people and those with advanced kidney disease. She is also experienced in research methods: cohort and cross sectional surveys, psychometrics, implementation and use of outcomes, especially the Integrated Palliative Care Outcome Scale.

Some of her current and recent projects are:

The PACE Project - Understanding facilitators and barriers to inform ongoing service development of the Integrated Care Service for older frail people at the Jean Bishop Centre, 2018-22. Funded by the University of Hull and Hull CCG: this project – in partnership with Dan Harman and colleagues at the Jean Bishop Centre – is evaluating this new innovative service and exploring future developments.

The Yorkshire and Humber Palliative Care Research Network - Addressing Inequalities Across All Ages, 2022-23. Funded by NIHR: this new research network (starting March 2022) will facilitate palliative care research across Yorkshire and Humber region, reaching out to new partners across the county.

RESOLVE - Improving health status and symptom experience for people living with advanced cancer, 2018-23. Funded by Yorkshire Cancer Research: the RESOLVE project continues Fliss' national work to implement outcome measures into palliative care, and to study best ways to do this.

Research England - International Investment Initiative (I3). Building Critical Mass, Increasing Scale and Impact For Palliative Care Through International Collaboration, 2019-2024. Building international collaboration to support and expand palliative care research; together with Miriam Johnson, Fliss works on a collaboration with University of Technology, Sydney, Australia.

Yorkshire Cancer Research TRANSFORM - Reducing inequalities in cancer outcomes in Yorkshire, 2017-2023. Funded by Yorkshire Cancer Research, this programme is developing innovation in diagnosis, patient management, survivorship, and palliative care research; Fliss is part of the executive leadership group for the programme.

Fliss' publications are available on her ORCID profile.

Prof Una Macleod

Prof Una Macleod

Dean and Professor of Primary Care Medicine, Hull York Medical School

Una Macleod became Dean of the Hull York Medical School on 1st January 2017. She joined the Medical School in 2010 as Professor of Primary Care Medicine and had previously worked in Glasgow, where she trained in Medicine and had been Senior Lecturer in General Practice and Primary Care and a half-time GP principal in the east end of the city. Her research interests revolve around primary care and cancer, and health inequalities. She is a national leader in the area of cancer and early diagnosis research, has contributed significantly to policy development, and holds or has held grants from Cancer Research UK, Yorkshire Cancer Research and the Department of Health Policy Research Unit programme in this area. She continues to work clinically as a GP at Bransholme Health Centre in Hull. She is a non-executive director at Hull University Teaching Hospitals, is a member of Medical Schools Council Executive and a member of the NIHR Advanced Fellowships panel.

Prof Makani Purva

Prof Makani Purva

Chief Medical Officer and Consultant Anaesthetist, Hull University Teaching Hospitals

Prof Makani Purva is Chief Medical Officer, Consultant Anaesthetist and Director of Simulation at the Hull Institute of Learning and Simulation.

Chairs

Prof Sunil Bhandari

Professor Bhandari is a Consultant in Nephrology and Honorary Professor at Hull York Medical School and Hull University Teaching Hospitals, Vice President for Royal College of Physicians Edinburgh, and a trustee for Kidney Research UK.

Prof Alyn Morice

Professor Morice is Head of Respiratory Medicine and the Centre for Cardiovascular and Metabolic Research at Hull York Medical School, based at the University of Hull. He is also an Honorary Consultant Physician at Hull University Teaching Hospitals.

Prof Thozhukat Sathyapalan

Prof Thozhukat Sathyapalan (Sathya) is the Chair in Academic Diabetes, Endocrinology and Metabolism in Hull York Medical School, University of Hull and Honorary Consultant Endocrinologist and Director of Research and Development at Hull University Teaching Hospitals.

Hull York Medical School
University of Hull Faculty of Health Sciences

Want to contact us?

We'd love to hear from you.